[Efficacy of combined paclitaxel/cetuximab in cutaneous squamous-cell carcinoma: A retrospective analysis of 14 patients]

Ann Dermatol Venereol. 2020 Apr;147(4):303-306. doi: 10.1016/j.annder.2019.07.009. Epub 2020 Mar 4.
[Article in French]
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma, Squamous Cell / drug therapy*
  • Carcinoma, Squamous Cell / radiotherapy
  • Carcinoma, Squamous Cell / secondary
  • Carcinoma, Squamous Cell / surgery
  • Cetuximab / administration & dosage
  • Combined Modality Therapy
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Lung Neoplasms / secondary
  • Lung Neoplasms / therapy
  • Male
  • Middle Aged
  • Paclitaxel / administration & dosage
  • Progression-Free Survival
  • Retrospective Studies
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / radiotherapy
  • Skin Neoplasms / surgery
  • Treatment Outcome

Substances

  • Paclitaxel
  • Cetuximab